The aim of this study was to assess the feasibility of transplanting mesenchymal stem cells (MSCs), genetically modified to express glial-derived neurotrophic factor (GDNF), to the contused rat spinal cord and to subsequently assess their neural differentiation potential. MSCs expressing green fluorescent protein (GFP) were transduced with a retroviral vector to express the neurotrophin GDNF. The transduction protocol was optimized by using GFP-expressing retroviral constructs; approximately 90% of MSCs were transduced successfully after G418 selection. GDNF-transduced MSCs expressed the transgene and secreted growth factor into the media (~12 ng/500,000 cells secreted into the supernatant 2 weeks after transduction). Injuries were established using an impactor device, which applied a given, reproducible force to the exposed spinal cord. GDNF-expressing MSCs were transplanted rostral and caudal 
Abstract
The aim of this study was to assess the feasibility of transplanting mesenchymal stem cells (MSCs), genetically modified to express glial-derived neurotrophic factor (GDNF), to the contused rat spinal cord and to subsequently assess their neural differentiation potential.
MSCs expressing green fluorescent protein (GFP) were transduced with a retroviral vector to express the neurotrophin GDNF. The transduction protocol was optimized by using GFP-expressing retroviral constructs; approximately 90% of MSCs were transduced successfully after G418 selection. GDNF-transduced MSCs expressed the transgene and secreted growth factor into the media (~12 ng/500,000 cells secreted into the supernatant 2 weeks after transduction). Injuries were established using an impactor device, which applied a given, reproducible force to the exposed spinal cord. GDNFexpressing MSCs were transplanted rostral and caudal to the site of injury. Spinal cord sections were analyzed 2 and 6 weeks after transplantation.
We demonstrate that GDNF-transduced MSCs engraft, survive and express the therapeutic gene up to 6 weeks post-transplantation, while maintaining an undifferentiated phenotype.
In conclusion, transplanted MSCs have limited capacity for the replacement of neural cells lost as a result of a spinal cord trauma. However, they provide excellent opportunities for local delivery of neurotrophic factors into the injured tissue. This study underlines the therapeutic benefits associated with cell transplantation and provides a good example of the use of MSCs for gene delivery. and to assess their ability to deliver a therapeutic factor to the site of injury over an extended period.
The neural differentiation potential of MSCs in vitro is controversial (1) (2) (3) (4) (5) , and the literature contains conflicting reports about the ability of MSCs to generate neural cells after transplantation into the CNS. Many studies report a low percentage of MSCs differentiating into astrocytes, oligodendrocytes, and neurons after transplantation into the CNS (6) (7) (8) , while other studies present no evidence for MSC differentiation (9-11).
Such variation may result from transplantation into embryonic versus adult animals or from the use of different animal models. Some concerns have also been raised about the use of 5-bromo-2-deoxyuridine and bis-benzamide as molecular labels. Such labels can be misleading because they may colocalize with endogenous cells and give a false impression of differentiation in the transplanted population (12) .
Rather than relying on the neural differentiation potential of MSCs, these cells may instead be used to modify the environment around a CNS injury site (11, 13, 14 These immunomodulatory characteristics may be of therapeutic value in the clinic where reducing inflammation is a central aspect of current treatment for human SCI;
methylprednisolone is a synthetic glucocorticoid that is currently used to reduce inflammation and edema at the site of injury. Indeed, bone marrow transplants are already in clinical use. For instance, in graft versus host disease (24) and for bone repair (25) . It is therefore a manageable step to consider isolating MSCs from the host, manipulating them in vitro and delivering them back to the host.
Gene therapy provides a means by which stem cells can be manipulated to deliver trophic molecules specific to a particular type of injury. Provision of glial-derived neurotrophic factor (GDNF) may stimulate the survival of injured motor neurons and promote axonal regeneration (26) . Effects of GDNF in vivo include improved survival of dopaminergic neurons in the striatum and midbrain in animal models of Parkinson disease (27); GDNF also promotes the survival and proliferation of enteric neuronal and glial progenitors in vitro (28) and in vivo (29) . Transplantation of GDNF-expressing MSCs to the injured spinal cord may provide a rich source of neurotrophic molecules and may also function as 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   7 a much-needed substrate for axonal growth and regeneration across the site of injury.
Indeed, MSCs have been shown to form guiding strands in the injured spinal cord that promote recovery (9) .
The objectives of this study were to determine whether MSCs could be genetically modified, using a retroviral vector, to express GDNF, and to subsequently assess the survival and differentiation potential of MSCs after transplantation into the contused spinal cord.
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Materials and Methods

Reagents
Gibco culture media were purchased from Invitrogen (Groningen, the Netherlands). 
GDNF-Retroviral Transduction of GFP-MSCs
GFP-MSCs, isolated from GFP transgenic rats, were transduced to express GDNF. We followed the same protocol that we used for GFP-retrovirus transfection of wild-type
MSCs. The G418 disulfate salt concentration that was deemed optimal for selection of transfected cells was 0.8 mg/mL.
A human GDNF enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Abingdon, United Kingdom), which qualitatively measures mouse and rat GDNF, was performed on the supernatant from these samples. The assay was performed according to the manufacturer's protocol. Transduction experiments were repeated in triplicate, and
ELISAs were performed on samples taken 12 days after transfection and G418 selection.
Characterization of GDNF-Transfected GFP-MSCs
GDNF-transduced transgenic GFP-MSCs were plated on chamber slides, allowed to adhere for 24 hours, and fixed with 4% paraformaldehyde. Immunocytochemistry analysis was performed on the fixed cells. 
Spinal Cord Injury
All animal experiments were approved by the Institutional Animal Care and Use
Committee of Ireland. Adult female Sprague-Dawley rats were anesthetized with intraperitoneal injections of ketamine and xylazine (dosage, 100 mg/kg and 10 mg/kg, respectively). The level of anesthesia was assessed by pinching the base of the tail or hind foot and by assessing the respiratory rate. Surgery was initiated only when the animal was completely insensitive to pain. The rate and adequacy of respiration, eye color, and response to pain was monitored throughout the surgical procedure.
Hair was removed from the rodent back (above the cervical and thoracic vertebrae) using electric clippers. The incision site was disinfected with a povidone-iodine solution.
Ointment containing mineral oil and petroleum jelly was applied to protect the animals'
eyes. Heating pad temperature was maintained at a constant 37°C during surgery. A 2-inch incision was made on the dorsal aspect of the spine, and a laminectomy was Saline solution (3.5 mL) was administered subcutaneously for 3 days after surgery. Food and water were provided in a manner such that injured animals would not have difficulty reaching them.
GFP-MSC and GDNF-Transduced GFP-MSC Transplantation Into the Contused
Spinal Cord
Seven days after surgery, 6 rats received GFP-MSCs (isolated from GFP transgenic rats), 6 rats received GDNF-transfected GFP-MSCs, and 6 rats received buffer alone as a control. MSCs were resuspended at a concentration of approximately 50,000 cells/µL in sterile buffer containing F12. Animals were anesthetized as described above, and the spinal cord was re-exposed. The spinal cord was held in place using a forceps gripping system. Two µL of cells or buffer were injected 1 mm rostral and caudal the site of injury using a Hamilton syringe with a 26-gauge needle (total injected volume, 4 µL). The syringe was placed in a stereotaxic frame, and the needle was lowered 1. give each rat a rating on the 21-point BBB locomotor rating scale. Animals were euthanized 2 or 6 weeks after cellular transplantation. Animals first were deeply anesthetized by an intraperitoneal injection of pentobarbital. The left ventricle was pierced using surgical scissors, and a cannula was inserted through the left ventricle into the ascending aorta. The cannula was clamped in place, and the right atrium was pierced to allow fixative to flow through the heart. After washing with at least 100 mL of perfusion wash (saline solution), 500 mL of perfusion fixative was administered; the flow was slow until stiffness of the limbs and tail was observed. The entire spinal cord, from cervical to sacral segments, was removed from the animal and fixed in 4% paraformaldehyde for 24 hours at 4°C. The spinal cord was placed in a 30% sucrose solution for 24 hours to cryoprotect the tissue. Afterward, the spinal cord was instantly frozen in liquid nitrogen-chilled isopentane and stored at -80°C until further processing.
Euthanasia and Tissue Harvesting
Spinal Cord Cryosection
Spinal cord tissue was sectioned into 20-µm slices in the rostral-to-caudal direction. Two sections were placed on 1 slide, and 4 slides were collected per sampling region (ie, 8
sections were collected per sampling region). Sampling regions were separated by 200 µm (ie, 10 section widths).
Immunohistochemical Analysis
Frozen sections were rehydrated by immersion in PBS buffer for 20 minutes, and the same immunohistochemistry protocol and antibodies (Table) were used. To counterstain all cell nuclei, DAPI was added to the sections (1 µg/mL, diluted in PBS) for 5 minutes.
Sections were washed 3 times in PBS, and a drop of mounting media (Dako, Carpenteria, California) was applied to the sections before a coverslip was applied. A negative control of each immunostaining procedure was performed by substituting PBS for the primary antibody.
Formatted: Line spacing: Double Deleted: described above Dehydrant was removed by washing twice in xylene for 15 minutes per wash. DPX mounting media and a cover slip were applied to each slide, and slides were incubated at 60°C overnight to solidify.
Stereologic Analysis
Stereologic analysis was performed to estimate the volume and number of GFP- GFP-MSCs were transduced with a GDNF-expressing retroviral vector. Analysis of the cell supernatant by ELISA showed GDNF secretion; 12 days after transfection and G418 selection, triplicate assays showed that GDNF levels were approximately 12 ng/500,000 cells, 48 hours after fresh media was placed on the cells (Figure 1 E) . 
Characterization of GDNF-Transduced GFP-MSCs
MSCs were characterized by their ability to differentiate into adipocytes and osteocytes, as previously published (16) . Further characterization of specific markers pertinent to this study was performed before transplantation of transduced cells.
Immunocytochemistry analysis of the GDNF-MSCs (Figure 2 
Spinal Cord Injury Contusion Model
Hematoxylin and eosin stains were used for histopathologic examination of the wound after contusion of the spinal cord, 48 hours after inducing the injury. A laminectomy was performed without contusion as a control, and in those animals, the transverse spinal cord remained intact with clearly distinguishable areas of white and gray matter (Figure 3 A) .
When the spinal cord was contused, however, an area of hemorrhage was evident on the dorsal surface of the spinal cord, above the central canal (Figure 3 B) . 
Outcome of GDNF-Transduced GFP-MSCs in the Contused
Functional analysis
Recovery of locomotor function was assessed using the BBB rating scale. No significant difference in BBB scores was evidenced between the groups tested ( Figure 6 ). All scores We have previously successfully transduced MSCs to express nerve growth factor using an adenoviral vector (16) . In this study, we clearly demonstrated that MSCs could also be transduced effectively by retroviral vectors to express the neurotrophin GDNF and that these MSCs could secrete GDNF for longer than 1 week in vitro. However, the concept of "physiologic levels" of growth factors is not readily modeled in vitro, and our objective therefore was to maintain expression of GDNF for several weeks after delivery of GDNF-transduced MSCs into the injured CNS.
Stereological analysis demonstrated that 20% of GFP-MSCs and GDNF-transfected GFP-MSCs survived 2 weeks after transplantation into the contused spinal cord. Those GDNF-transduced GFP-MSCs that were detected at 2 weeks and 6 weeks, continued to This lack of co-localization prevented us from estimating the percentage of transplanted cells which were still GDNF-positive. GDNF expression was not documented in the animals that received buffer alone or GFP-MSCs alone, which indicates that the presence of GDNF in the GDNF-GFP-MSC transplanted group was due to the presence of the transgene in the transplanted cells. We found no evidence of MSC differentiation after transplantation into the CNS, which was consistent with previous studies (9-11). Here, we showed that MSCs were useful stem cell candidates for delivery of trophic molecules into the injured nervous system. These cells were easy to isolate and propagate in vitro and could be genetically modified to express neurotrophins. We also showed that cells isolated from transgenic animals were reliable (ie, capable of long-term expression of GFP and GDNF). From a clinical perspective, MSCs are advantageous because they 
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